BrightAccountsProduction v1.0.0 v1.0.0 2025-06-01 The company was not dormant during the period The company was trading for the entire period Unaudited Accounts The principal activity of the company under review was the provision of natural health services. 1 August 2026 4 4 11991675 2026-05-31 11991675 2025-05-31 11991675 2024-05-31 11991675 2025-06-01 2026-05-31 11991675 2024-06-01 2025-05-31 11991675 uk-bus:PrivateLimitedCompanyLtd 2025-06-01 2026-05-31 11991675 uk-curr:PoundSterling 2025-06-01 2026-05-31 11991675 uk-bus:FullAccounts 2025-06-01 2026-05-31 11991675 uk-bus:Director1 2025-06-01 2026-05-31 11991675 uk-bus:RegisteredOffice 2025-06-01 2026-05-31 11991675 uk-bus:Agent1 2025-06-01 2026-05-31 11991675 uk-core:ShareCapital 2026-05-31 11991675 uk-core:ShareCapital 2025-05-31 11991675 uk-core:SharePremium 2026-05-31 11991675 uk-core:SharePremium 2025-05-31 11991675 uk-core:RetainedEarningsAccumulatedLosses 2026-05-31 11991675 uk-core:RetainedEarningsAccumulatedLosses 2025-05-31 11991675 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2026-05-31 11991675 uk-core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests 2025-05-31 11991675 uk-bus:FRS102 2025-06-01 2026-05-31 11991675 uk-core:Goodwill 2025-06-01 2026-05-31 11991675 uk-core:FurnitureFittingsToolsEquipment 2025-06-01 2026-05-31 11991675 uk-core:Goodwill 2025-05-31 11991675 uk-core:Goodwill 2026-05-31 11991675 uk-core:WithinOneYear 2026-05-31 11991675 uk-core:WithinOneYear 2025-05-31 11991675 2025-06-01 2026-05-31 11991675 uk-bus:AuditExempt-NoAccountantsReport 2025-06-01 2026-05-31 xbrli:pure iso4217:GBP xbrli:shares
Company Registration Number: 11991675
 
 
Helix House Natural Health Limited
 
Director's Report and Unaudited Financial Statements
 
for the financial year ended 31 May 2026



Helix House Natural Health Limited
DIRECTOR AND OTHER INFORMATION

 
Director Mr Yan-Chee Yu
 
 
Company Registration Number 11991675
 
 
Registered Office and Business Address 15 Warwick Street
Oxford
Oxfordshire
OX4 1SZ
United Kingdom
 
 
Accountants Cook the Books Limited
10 Leighton Industrial Park
Billington Road
Leighton Buzzard
LU7 4AJ



Helix House Natural Health Limited
DIRECTOR'S REPORT
for the financial year ended 31 May 2026

 
The director presents their report and the unaudited financial statements for the financial year ended 31 May 2026.
     
Director
The director who served during the financial year is as follows:
     
Mr Yan-Chee Yu
   
There were no changes in shareholdings between 31 May 2026 and the date of signing the financial statements.
     
Special provisions relating to small companies
The above report has been prepared in accordance with the special provisions relating to small companies within Part 15 of the Companies Act 2006.
     
     
On behalf of the board
     
     
___________________________
Mr Yan-Chee Yu
Director
     
1 August 2026



Helix House Natural Health Limited
INCOME STATEMENT
for the financial year ended 31 May 2026
2026 2025
Notes £ £

Turnover 124,134 105,019
 
Cost of sales (20,501) (13,817)
───────── ─────────
Gross profit 103,633 91,202
 
Administrative expenses (124,322) (122,750)
Other operating income 10,656 10,213
───────── ─────────
Loss before taxation (10,033) (21,335)
 
Tax on loss - -
───────── ─────────
Loss for the financial year (10,033) (21,335)
───────── ─────────
Total comprehensive income (10,033) (21,335)
    ═════════   ═════════



Helix House Natural Health Limited
Company Registration Number: 11991675
STATEMENT OF FINANCIAL POSITION
as at 31 May 2026

2026 2025
Notes £ £
 
Non-Current Assets
Property, plant and equipment 5 171 280
───────── ─────────
 
Current Assets
Debtors 6 888 888
Cash and cash equivalents 3,894 2,653
───────── ─────────
4,782 3,541
───────── ─────────
Creditors: amounts falling due within one year 7 (76,264) (65,099)
───────── ─────────
Net Current Liabilities (71,482) (61,558)
───────── ─────────
Total Assets less Current Liabilities (71,311) (61,278)
═════════ ═════════
 
Capital and Reserves
Called up share capital 240 240
Share premium account 8 50,400 50,400
Retained earnings (121,951) (111,918)
───────── ─────────
Shareholders' Deficit (71,311) (61,278)
═════════ ═════════
 
The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A (Small Entities).
           
For the financial year ended 31 May 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006.
           
The director confirms that the members have not required the company to obtain an audit of its financial statements for the financial year in question in accordance with section 476 of the Companies Act 2006.
           
The director acknowledges their responsibilities for ensuring that the company keeps accounting records which comply with section 386 and for preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of the financial year and of its profit and loss for the financial year in accordance with the requirements of sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.
           
Approved by the Director and authorised for issue on 1 August 2026
           
           
________________________________          
Mr Yan-Chee Yu          
Director          
           



Helix House Natural Health Limited
NOTES TO THE FINANCIAL STATEMENTS
for the financial year ended 31 May 2026

   
1. General Information
 
Helix House Natural Health Limited is a company limited by shares incorporated and registered in the England and Wales. The registered number of the company is 11991675. The registered office of the company is 15 Warwick Street, Oxford, Oxfordshire, OX4 1SZ, United Kingdom which is also the principal place of business of the company. The principal activity of the company under review was the provision of natural health services. The financial statements have been presented in Pound (£) which is also the functional currency of the company.
         
2. Summary of Significant Accounting Policies
 
The following accounting policies have been applied consistently in dealing with items which are considered material in relation to the company's financial statements.
 
Statement of compliance
The financial statements of the company for the financial year ended 31 May 2026 have been prepared in accordance with the provisions of FRS 102 Section 1A (Small Entities) and the Companies Act 2006.
 
Basis of preparation
The financial statements have been prepared on the going concern basis and in accordance with the historical cost convention except for certain properties and financial instruments that are measured at revalued amounts or fair values, as explained in the accounting policies below. Historical cost is generally based on the fair value of the consideration given in exchange for assets.
 
Turnover
Turnover comprises the invoice value of goods supplied by the company, exclusive of trade discounts and value added tax.
 
Goodwill
Purchased goodwill arising on the acquisition of a business represents the excess of the acquisition cost over the fair value of the identifiable net assets including other intangible fixed assets when they were acquired. Purchased goodwill is capitalised in the Statement of Financial Position and amortised on a straight line basis over its economic useful life of 0 years, which is estimated to be the period during which benefits are expected to arise.  On disposal of a business any goodwill not yet amortised is included in determining the profit or loss on sale of the business.
 
Property, plant and equipment and depreciation
Property, plant and equipment are stated at cost or at valuation, less accumulated depreciation. Cost comprises purchase price and other directly attributable costs. The charge to depreciation is calculated to write off the original cost or valuation of property, plant and equipment, less their estimated residual value, over their expected useful lives as follows:
 
  Fixtures, fittings and equipment - 25% & 33% Straight line
 
The carrying values of tangible fixed assets are reviewed annually for impairment in periods if events or changes in circumstances indicate the carrying value may not be recoverable.
 
Trade and other debtors
Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.
 
Trade and other creditors
Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.
 
Employee benefits
The company operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund. The company also operates a defined benefit pension scheme for its employees providing benefits based on final pensionable pay. The assets of this scheme are also held separately from those of the company, being invested with pension fund managers.
 
Taxation and deferred taxation

Current tax represents the amount expected to be paid or recovered in respect of taxable profits for the financial year and is calculated using the tax rates and laws that have been enacted or substantially enacted at the Statement of Financial Position date.

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date where transactions or events have occurred at that date that will result in an obligation to pay more tax in the future, or a right to pay less tax in the future. Timing differences are temporary differences between the company's taxable profits and its results as stated in the financial statements.

Deferred tax is measured on an undiscounted basis at the tax rates that are anticipated to apply in the periods in which the timing differences are expected to reverse, based on tax rates and laws that have been enacted or substantively enacted by the Statement of Financial Position date.

 
Foreign currencies
Monetary assets and liabilities denominated in foreign currencies are translated at the rates of exchange ruling at the Statement of Financial Position date. Non-monetary items that are measured in terms of historical cost in a foreign currency are translated at the rates of exchange ruling at the date of the transaction. Non-monetary items that are measured at fair value in a foreign currency are translated using the exchange rates at the date when the fair value was determined. The resulting exchange differences are dealt with in the Income Statement.
 
Ordinary share capital
The ordinary share capital of the company is presented as equity.
       
3. Employees
 
The average monthly number of employees, including director, during the financial year was 4, (2025 - 4).
 
  2026 2025
  Number Number
 
Administration 4 4
  ═════════ ═════════
       
4. Intangible assets
     
  Goodwill Total
  £ £
Cost
At 1 June 2025 50,400 50,400
  ───────── ─────────
 
At 31 May 2026 50,400 50,400
  ───────── ─────────
Amortisation
 
At 31 May 2026 50,400 50,400
  ───────── ─────────
Net book value
At 31 May 2026 - -
  ═════════ ═════════
       
5. Property, plant and equipment
  Fixtures, Total
  fittings and  
  equipment  
  £ £
Cost
At 1 June 2025 1,773 1,773
  ───────── ─────────
 
At 31 May 2026 1,773 1,773
  ───────── ─────────
Depreciation
At 1 June 2025 1,493 1,493
Charge for the financial year 109 109
  ───────── ─────────
At 31 May 2026 1,602 1,602
  ───────── ─────────
Net book value
At 31 May 2026 171 171
  ═════════ ═════════
At 31 May 2025 280 280
  ═════════ ═════════
       
6. Debtors 2026 2025
  £ £
 
Prepayments and accrued income 888 888
  ═════════ ═════════
       
7. Creditors 2026 2025
Amounts falling due within one year £ £
 
Director's current account 72,025 61,800
Other creditors 48 27
Accruals:
Pension accrual 488 -
Other accruals 3,703 3,272
  ───────── ─────────
  76,264 65,099
  ═════════ ═════════
   
8. Reserves
 
Share Premium Reserve
 
The amount carried forward is the premium that arose from the issue of shares in 2010.
 
   
9. Events After the End of the Reporting Period
 
There have been no significant events affecting the company since the financial year-end.